MedPath

Gasless Single-port Laparoscopic-assisted Radical Resection for Rectal Carcinoma

Not Applicable
Conditions
Laparoscopic Surgery
Registration Number
NCT03318185
Lead Sponsor
The Second Affiliated Hospital of Chongqing Medical University
Brief Summary

This project aims to investigate the safety and effectiveness of gasless single-port laparoscopic-assisted radical resection (GSLR) in the treatment of rectal carcinoma.

Detailed Description

The gasless single-port laparoscopic-assisted surgery (GSLS) is associated with rapid recovery and shorter postoperative hospital stay and no pneumoperitoneum complications occur after the operation. To our knowledge, there have been no reports about GSLS applied to the treatment of gastrointestinal cancer in the world. To explore the safety and effectiveness of GSLS in rectal cancer patients, this project plans to evaluate the operation time, cardio-pulmonary function, postoperative pain, immunologic function and restoration of bowel function after the operation.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Rectal carcinoma;The distance between tumor and anal verge is 5-15cm; The primary tumor can radical resect.
Exclusion Criteria
  • Neoadjuvant therapy;Surgical contraindication.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Pulmonary functionChange from baseline PaO2/FiO2 ratio 10 minutes after the surgery is over.

Estimate the pulmonary function in the perioperational period by blood gas analysis, which will be compared with comparator.The main parameter partial pressure of oxygen(PaO2)/inspired oxygen fraction(FiO2) ratio is the ratio of arterial oxygen partial pressure to fractional inspired oxygen.

Immunologic functionChange from baseline CD4/CD8 ratio 7 days after operation.

Estimate the immunologic function in the perioperational period by blood lymphocyte analysis, which will be compared with comparator.The main parameter cluster of differentiation 4(CD4)/cluster of differentiation 8(CD8) ratio is the ratio of lymphocyte CD4 numbers to lymphocyte CD8 numbers.

Secondary Outcome Measures
NameTimeMethod
Number of the lymph node dissectionat 1 week after operation

Measure the number of the regional lymph node dissection after operation, which will be compared with comparator.

Operation timeat 1 day

Measure the operation time, which will be compared with comparator.

Postoperative pain72 hours after operation

Measure the postoperative pain after operation by numerical rating scale(NRS), which will be compared with comparator.

Bowel functionup to 1 week after operation

Measure the restoration of bowel function after operation, which will be compared with comparator.The bowel function was evaluated by first flatus.

Trial Locations

Locations (1)

Gastrointestinal Surgery Department of the Second Affiliated Hospital of Chongqing Medical University

🇨🇳

Chongqing, Chongqing, China

Gastrointestinal Surgery Department of the Second Affiliated Hospital of Chongqing Medical University
🇨🇳Chongqing, Chongqing, China
Jijian Wang, MD,phD
Contact
86-23-63693511
wangjj1963@163.com
Jianbo Zhang, MD,phD
Contact
86-23-63693510
172329491@qq.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.